L-AP4

From WikiMD's WELLNESSPEDIA

L-AP4 (or L-2-amino-4-phosphonobutyric acid) is a pharmacological agent that acts as a group III metabotropic glutamate receptor agonist. It is used in scientific research to understand the function and role of these receptors in the body.

Chemistry[edit]

L-AP4 is a derivative of the amino acid glutamic acid, with a phosphonate group replacing the second carboxyl group. This modification allows it to bind to and activate group III metabotropic glutamate receptors, which are not normally responsive to glutamic acid itself.

Pharmacology[edit]

L-AP4 is an agonist for the group III metabotropic glutamate receptors (mGluRs). These receptors are a type of G protein-coupled receptor that respond to the neurotransmitter glutamate. They are found in various parts of the body, but are particularly concentrated in the central nervous system, where they play a role in modulating neuronal excitability and synaptic plasticity.

Research Use[edit]

In scientific research, L-AP4 is used to study the function and role of group III mGluRs. By selectively activating these receptors, researchers can investigate their effects on neuronal activity and behavior. This has led to insights into a variety of neurological and psychiatric conditions, including schizophrenia, depression, and epilepsy.

Safety[edit]

As a research chemical, L-AP4 is not intended for human consumption. Its safety profile in humans is not well-studied, and it should be handled with appropriate caution in the laboratory setting.

See Also[edit]

This article is a stub related to pharmacology. You can help WikiMD by expanding it!


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.